Tag: GLP-1 drugs

Altcoins

Planet Fitness Stock Boost From Weight Loss Drugs

As more people turn to weight-loss medications, one gym chain could see a major membership surge. Analysts are bullish on...

16/01/2026

2 views

Read More

Altcoins

Novo Nordisk GLP-1 Pill: Pricing Pressures & 2026 Outlook

At JPMorgan 2026, Novo Nordisk's CEO warned of major price pressure on GLP-1 drugs this year, even as their new...

14/01/2026

4 views

Read More

Market News

2026 The Rise of Obesity Pills Reshaping Weight Loss

As 2026 kicks off, the weight loss world is about to change dramatically. New pills are stepping up to challenge...

10/01/2026

1 views

Read More

Market News

Amazon Pharmacy Now Offers Wegovy Weight Loss Pill

Amazon just made a major move in the weight loss world by adding Novo Nordisk's brand-new Wegovy pill to its...

09/01/2026

2 views

Read More

Market News

Eli Lilly Stock Drop: Novo Nordisk Pill Impact and Market Rally

Eli Lilly shares are tumbling today as a major competitor just launched an oral weight loss pill in the US....

05/01/2026

4 views

Read More

Growth Picks

2026 GLP-1 Weight Loss Pills: Top Stocks to Watch

As oral GLP-1 weight loss pills hit the market in 2026, millions more people will adopt healthier habits—shifting spending on...

01/01/2026

4 views

Read More

Global Companies

Novo Nordisk’s Must-Win Battle for Wegovy in 2026

Novo Nordisk just got its Wegovy pill approved – a potential game-changer after a brutal year. But with Eli Lilly...

01/01/2026

4 views

Read More

Market News

Novo Nordisk Shares Surge After Wegovy Pill FDA Approval

After a tough year of declining shares and fierce competition, Novo Nordisk just scored a massive victory with the FDA's...

26/12/2025

1 views

Read More

Market News

Why Eli Lilly Investors Should Ignore Novo Nordisk’s Obesity Pill Lead

Novo Nordisk just scored FDA approval for the first obesity pill, sending its shares soaring while Eli Lilly dipped. But...

23/12/2025

2 views

Read More

Growth Picks

Why Eli Lilly Stock Deserves to Be Higher in 2025

The market cheered cooler inflation numbers today, but one big pharma name is still flying under the radar despite groundbreaking...

18/12/2025

5 views

Read More